Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

V.P. Bykerk, A.J.K. Ostor, J. Alvaro-Gracia, K. Pavelka, J.A.R. Ivorra, W. Graninger, W. Bensen, M.T. Nurmohamed, A. Krause, C. Bernasconi, M. Aassi, J Sibilia

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)563-571
JournalClinical Rheumatology
Issue number3
Publication statusPublished - 2015

Cite this